190 related articles for article (PubMed ID: 7911548)
1. Expression of the multidrug resistance-associated protein (MRP) in acute and chronic leukemias.
Burger H; Nooter K; Zaman GJ; Sonneveld P; van Wingerden KE; Oostrum RG; Stoter G
Leukemia; 1994 Jun; 8(6):990-7. PubMed ID: 7911548
[TBL] [Abstract][Full Text] [Related]
2. High expression of two diverged homeobox genes, HB24 and HB9, in acute leukemias: molecular markers of hematopoietic cell immaturity.
Deguchi Y; Yamanaka Y; Theodossiou C; Najfeld V; Kehrl JH
Leukemia; 1993 Mar; 7(3):446-51. PubMed ID: 7680402
[TBL] [Abstract][Full Text] [Related]
3. Argyrophilic nucleolar organizer regions (AgNORs) in relation to p53 and bcl-2 protein expression in leukemia patients.
Klobusická M; Kusenda J; Babusíková O
Neoplasma; 2003; 50(6):408-15. PubMed ID: 14689061
[TBL] [Abstract][Full Text] [Related]
4. Ubiquitous expression of cytokines in diverse leukemias of lymphoid and myeloid lineage.
Kurzrock R; Kantarjian H; Wetzler M; Estrov Z; Estey E; Troutman-Worden K; Gutterman JU; Talpaz M
Exp Hematol; 1993 Jan; 21(1):80-5. PubMed ID: 8417962
[TBL] [Abstract][Full Text] [Related]
5. Expression of complement regulatory proteins CR1, DAF, MCP and CD59 in haematological malignancies.
Guc D; Canpinar H; Kucukaksu C; Kansu E
Eur J Haematol; 2000 Jan; 64(1):3-9. PubMed ID: 10680700
[TBL] [Abstract][Full Text] [Related]
6. P-glycoprotein and drug resistance in acute leukemias and in the blastic crisis of chronic myeloid leukemia.
Carulli G; Petrini M; Marini A; Vaglini F; Caracciolo F; Grassi B
Haematologica; 1990; 75(6):516-21. PubMed ID: 1982999
[TBL] [Abstract][Full Text] [Related]
7. Expression of the multidrug resistance-associated protein (MRP) gene in human cancers.
Nooter K; Westerman AM; Flens MJ; Zaman GJ; Scheper RJ; van Wingerden KE; Burger H; Oostrum R; Boersma T; Sonneveld P
Clin Cancer Res; 1995 Nov; 1(11):1301-10. PubMed ID: 9815925
[TBL] [Abstract][Full Text] [Related]
8. Presence of Wilms' tumor gene (wt1) transcripts and the WT1 nuclear protein in the majority of human acute leukemias.
Menssen HD; Renkl HJ; Rodeck U; Maurer J; Notter M; Schwartz S; Reinhardt R; Thiel E
Leukemia; 1995 Jun; 9(6):1060-7. PubMed ID: 7596170
[TBL] [Abstract][Full Text] [Related]
9. Coexpression of p53 protein and MDR functional phenotype in leukemias: the predominant association in chronic myeloid leukemia.
Cavalcanti GB; Vasconcelos FC; Pinto de Faria G; Scheiner MA; de Almeida Dobbin J; Klumb CE; Maia RC
Cytometry B Clin Cytom; 2004 Sep; 61(1):1-8. PubMed ID: 15351976
[TBL] [Abstract][Full Text] [Related]
10. Coexpression of anionic glutathione-S-transferase (GST pi) and multidrug resistance (mdr1) genes in acute myeloid and lymphoid leukemias.
Russo D; Marie JP; Zhou DC; Faussat AM; Delmer A; Maisonneuve L; Ngoc LH; Baccarani M; Zittoun R
Leukemia; 1994 May; 8(5):881-4. PubMed ID: 7910222
[TBL] [Abstract][Full Text] [Related]
11. High expression of the multidrug resistance-associated protein (MRP) in chronic and prolymphocytic leukaemia.
Burger H; Nooter K; Sonneveld P; Van Wingerden KE; Zaman GJ; Stoter G
Br J Haematol; 1994 Oct; 88(2):348-56. PubMed ID: 7803281
[TBL] [Abstract][Full Text] [Related]
12. Analysis of multidrug resistance-associated protein (MRP) messenger RNA in normal and malignant hematopoietic cells.
Abbaszadegan MR; Futscher BW; Klimecki WT; List A; Dalton WS
Cancer Res; 1994 Sep; 54(17):4676-9. PubMed ID: 8062263
[TBL] [Abstract][Full Text] [Related]
13. Expression of gene encoding P65 oncofetal protein in acute and chronic leukemias.
Balcerczak E; Bartkowiak J; Błoński JZ; Robak T; Mirowski M
Neoplasma; 2002; 49(5):295-9. PubMed ID: 12458326
[TBL] [Abstract][Full Text] [Related]
14. [Expression of lung resistance protein and multidrug resistance-associated protein in naive childhood acute leukemia and their clinical significance].
Zhang JB; Sun Y; Dong J; Liu LX; Ning F
Ai Zheng; 2005 Aug; 24(8):1015-7. PubMed ID: 16086885
[TBL] [Abstract][Full Text] [Related]
15. Mdr1/P-glycoprotein, topoisomerase, and glutathione-S-transferase pi gene expression in primary and relapsed state adult and childhood leukaemias.
Gekeler V; Frese G; Noller A; Handgretinger R; Wilisch A; Schmidt H; Muller CP; Dopfer R; Klingebiel T; Diddens H
Br J Cancer; 1992 Sep; 66(3):507-17. PubMed ID: 1355660
[TBL] [Abstract][Full Text] [Related]
16. Increased expression of protease-activated receptor 1 (PAR-1) in human leukemias.
Veiga Cde S; Carneiro-Lobo TC; Coelho CJ; Carvalho SM; Maia RC; Vasconcelos FC; Abdelhay E; Mencalha AL; Ferreira AF; Castro FA; Monteiro RQ
Blood Cells Mol Dis; 2011 Mar; 46(3):230-4. PubMed ID: 21216163
[TBL] [Abstract][Full Text] [Related]
17. Variable expression of CD49d antigen in B cell chronic lymphocytic leukemia is related to disease stages.
Eksioğlu-Demiralp E; Alpdoğan O; Aktan M; Firatli T; Oztürk A; Budak T; Bayik M; Akoğlu T
Leukemia; 1996 Aug; 10(8):1331-9. PubMed ID: 8709639
[TBL] [Abstract][Full Text] [Related]
18. Multidrug resistance-associated protein in acute myeloid leukemia: No impact on treatment outcome.
Filipits M; Suchomel RW; Zöchbauer S; Brunner R; Lechner K; Pirker R
Clin Cancer Res; 1997 Aug; 3(8):1419-25. PubMed ID: 9815827
[TBL] [Abstract][Full Text] [Related]
19. Alterations of cyclin-dependent kinase 4 inhibitor (p16INK4A/MTS1) gene structure and expression in acute lymphoblastic leukemias.
Delmer A; Tang R; Senamaud-Beaufort C; Paterlini P; Brechot C; Zittoun R
Leukemia; 1995 Jul; 9(7):1240-5. PubMed ID: 7630199
[TBL] [Abstract][Full Text] [Related]
20. The dual role of HLXB9 in leukemia.
Ferguson S; Gautrey HE; Strathdee G
Pediatr Blood Cancer; 2011 Mar; 56(3):349-52. PubMed ID: 21069786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]